Recent FBRX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:29:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:42:13 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/13/2026 01:14:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 01:01:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/09/2026 08:12:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 10:14:14 AM
- Forte Biosciences Announces Pricing of $150 Million Public Offering • Business Wire • 04/09/2026 01:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/08/2026 08:22:20 PM
- Forte Biosciences Announces Proposed Public Offering • Business Wire • 04/08/2026 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 12:00:07 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/07/2025 06:43:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/03/2025 08:20:51 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/25/2025 09:22:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 08:45:18 PM
- Forte Biosciences Announces Pricing of $75 Million Public Offering • Business Wire • 06/25/2025 04:28:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/24/2025 08:41:39 PM
- Forte Biosciences Announces Proposed Public Offering • Business Wire • 06/24/2025 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 11:47:28 AM
